Related Experiment Videos
Managing anemia in the critically ill patient
Maria I Rudis1, Judith Jacobi, Erkan Hassan
1Department of Pharmacy, School of Pharmacy, University of Southern California, Los Angeles, California 90033, USA. rudis@hsc.usc.edu
Pharmacotherapy
|March 5, 2004
Summary
Anemia of critical illness, common in intensive care units, stems from blood loss and poor red blood cell production. Alternatives to red blood cell transfusions are being explored for managing this condition.
Area of Science:
- Critical care medicine
- Hematology
- Intensive care unit management
Background:
- Anemia of critical illness is a common, multifactorial condition.
- It arises early in critical illness due to blood loss and reduced red blood cell production.
- Red blood cell transfusion is the standard immediate treatment in intensive care units.
Purpose of the Study:
- To review the causes and management of anemia in critically ill patients.
- To discuss therapeutic options beyond red blood cell transfusion.
- To highlight the ongoing debate regarding transfusion triggers.
Main Methods:
- Literature review of anemia in critical illness.
- Analysis of current and investigational therapeutic strategies.
- Discussion of clinical evidence and cost-effectiveness.
Main Results:
- Anemia of critical illness has multiple contributing factors.
- Debate exists regarding optimal transfusion thresholds (hemoglobin/hematocrit).
- Alternative treatments include blood conservation, minimizing blood draws, erythropoietic agents, and oxygen carriers.
Conclusions:
- Minimizing phlebotomy and exploring alternatives to transfusion are crucial.
- Erythropoietic agents may offer an alternative, but further research on outcomes and cost is needed.
- Optimizing anemia management in critical illness requires a comprehensive approach.